A double-blind, placebo-controlled, randomized trial to evaluate the safety and 
efficacy of Cerebrolysin in patients with Acute ischaemic Stroke in Asia - CASTA

Hong, Z.; Moessler, H.; Bornstein, N.; Brainin, M.; Heiss, Wolf-Dieter

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with Acute ischaemic Stroke in Asia - CASTA

MPS-Authors

/persons/resource/persons147188

Heiss, Wolf-Dieter
Wolf-Dieter Heiss, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Hong, Z., Moessler, H., Bornstein, N., Brainin, M., & Heiss, W.-D. (2009). A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with Acute ischaemic Stroke in Asia - CASTA. International Journal of Stroke, 4(5), 406-412.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D1F8-D

Abstract

There is no abstract available